All data are based on the daily closing price as of December 10, 2025
s
Shinpoong Pharm
019170.KO
10.03 USD
0.15
+1.52%
Overview
Last close
10.03 usd
Market cap
494.19M usd
52 week high
14.06 usd
52 week low
4.50 usd
Target price
3.92 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
3.2627
Price/Book Value
2.8336
Enterprise Value
499.07M usd
EV/Revenue
3.1648
EV/EBITDA
59.0365
Key financials
Revenue TTM
157.70M usd
Gross Profit TTM
65.99M usd
EBITDA TTM
6.72M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
243.87M usd
Net debt
5.85M usd
About
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.